Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination
Pierre Mordant(Université Paris Cité), Éric Deutsch(Université Paris-Sud)
Cited by 48
Related Papers
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
|Cell Death and Differentiation|2013|195
Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer
|Cell Death and Disease|2014|45